{
    "eid": "2-s2.0-85081018715",
    "title": "VE1 immunohistochemistry improves the limit of genotyping for detecting BRAFV600E mutation in papillary thyroid cancer",
    "cover-date": "2020-03-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Oncology",
            "@code": "2730",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Cancer Research",
            "@code": "1306",
            "@abbrev": "BIOC"
        }
    ],
    "keywords": [
        "BRAF",
        "Diagnostic performance",
        "Immunohistochemistry",
        "Papillary thyroid carcinoma",
        "VE1"
    ],
    "authors": [
        "Sonam Choden",
        "Somboon Keelawat",
        "Chan Kwon Jung",
        "Andrey Bychkov"
    ],
    "citedby-count": 17,
    "ref-count": 55,
    "ref-list": [
        "Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries",
        "Worldwide Thyroid-Cancer Epidemic? The Increasing Impact of Overdiagnosis",
        "Worldwide increasing incidence of thyroid cancer: Update on epidemiology and risk factors",
        "Overall Survival of Papillary Thyroid Carcinoma Patients: A Single-Institution Long-Term Follow-Up of 5897 Patients",
        "Biologic and Clinical Perspectives on Thyroid Cancer",
        "Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features in Asian Practice: Perspectives for Surgical Pathology and Cytopathology",
        "Mutations of the BRAF gene in human cancer",
        "BRAF mutation in papillary thyroid cancer: Pathogenic role, molecular bases, and clinical implications",
        "Prognostic utility of BRAF mutation in papillary thyroid cancer",
        "Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer",
        "Associations between BRAF(V600E) and prognostic factors and poor outcomes in papillary thyroid carcinoma: A meta-analysis",
        "BRAF V600E Mutation-Assisted Risk Stratification of Solitary Intrathyroidal Papillary Thyroid Cancer for Precision Treatment",
        "Mutated BRAF and personalised medicine in differentiated thyroid cancer",
        "Protein kinase inhibitors for the treatment of advanced and progressive radiorefractory thyroid tumors: From the clinical trials to the real life",
        "Mutation Profile of Well-Differentiated Thyroid Cancer in Asians",
        "Prevalence of BRAF(V600E) mutation in Asian patients with thyroid cancer",
        "Immunohistochemical Investigation of BRAF p.V600E mutations in thyroid carcinoma using 2 separate BRAF antibodies",
        "Value of immunohistochemistry in the detection of BRAF(V600E) mutations in fine-needle aspiration biopsies of papillary thyroid carcinoma",
        "A combination of immunohistochemistry and molecular approaches improves highly sensitive detection of BRAF mutations in papillary thyroid cancer",
        "Comparison of Immunohistochemistry and Direct Sanger Sequencing for Detection of the BRAF(V600E) Mutation in Thyroid Neoplasm",
        "Analysis of immunocytochemical and molecular BRAF expression in thyroid carcinomas: A cytohistologic institutional experience",
        "Detection of BRAF mutation in Chinese tumor patients using a highly sensitive antibody immunohistochemistry assay",
        "Immunohistochemistry cannot replace DNA analysis for evaluation of BRAF V600E mutations in papillary thyroid carcinoma",
        "Comparison of 2 monoclonal antibodies for immunohistochemical detection of BRAF V600E mutation in malignant melanoma, pulmonary carcinoma, gastrointestinal carcinoma, thyroid carcinoma, and gliomas",
        "Clinical utility of immunohistochemistry for the detection of the BRAF v600e mutation in papillary thyroid carcinoma",
        "Next generation immunohistochemistry: Emerging substitutes to genetic testing?",
        "Peptide Antibodies in Clinical Laboratory Diagnostics",
        "Peptides, Antibodies, Peptide Antibodies and More",
        "Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibody",
        "Utilization of a MAB for BRAF(V600E) detection in papillary thyroid carcinoma",
        "Diagnostic value of immunohistochemistry for the detection of the BRAF(V600E) mutation in papillary thyroid carcinoma: Comparative analysis with three DNA-based assays",
        "VE1 immunohistochemical detection of the BRAF V600E mutation in thyroid carcinoma: A review of its usefulness and limitations",
        "BRAF Immunohistochemistry Using Clone VE1 is Strongly Concordant with BRAF(V600E) Mutation Test in Papillary Thyroid Carcinoma",
        "Specific immunohistochemical detection of the BRAF V600E mutation in primary and metastatic papillary thyroid carcinoma",
        "BRAF V600E mutation-specific antibody: A review",
        "A Systematic Review and Meta-Analysis of the Diagnostic Performance of BRAF V600E Immunohistochemistry in Thyroid Histopathology",
        "Immunohistochemistry with the anti-BRAF V600E (VE1) antibody: Impact of pre-analytical conditions and concordance with DNA sequencing in colorectal and papillary thyroid carcinoma",
        "Immunohistochemistry is highly sensitive and specific for detecting the BRAF V600E mutation in papillary thyroid carcinoma",
        "Comparison of Immunohistochemistry and Direct Sequencing Methods for Identification of the BRAF(V600E) Mutation in Papillary Thyroid Carcinoma",
        "Clinicopathologic correlations of the BRAFV600E mutation, BRAF V600E immunohistochemistry, and BRAF RNA in situ hybridization in papillary thyroid carcinoma",
        "Immunohistochemistry as an accurate tool for evaluating BRAF-V600E mutation in 130 samples of papillary thyroid cancer",
        "Immunohistochemical detection of the BRAF V600E mutation in papillary thyroid carcinoma. Evaluation against real-time polymerase chain reaction. Endocrinol",
        "Immunohistochemistry is a feasible method to screen BRAF V600E mutation in colorectal and papillary thyroid carcinoma",
        "Comparison of diagnostic methods for the detection of a BRAF mutation in papillary thyroid cancer",
        "A testing algorithm for detection of the B-type Raf kinase V600E mutation in papillary thyroid carcinoma",
        "The prognostic significance of the BRAF V600E mutation in papillary thyroid carcinoma detected by mutation-specific immunohistochemistry",
        "Immunohistochemical testing of BRAF V600E status in 1,120 tumor tissue samples of patients with brain metastases",
        "Immunohistochemistry for BRAF(V600E) antibody VE1 performed in core needle biopsy samples identifies mutated papillary thyroid cancers",
        "2019 Practice guidelines for thyroid core needle biopsy: A report of the Clinical Practice Guidelines Development Committee of the Korean Thyroid Association",
        "BRAF mutation in papillary thyroid carcinoma",
        "Clinical utility of EZH1 mutations in the diagnosis of follicular-patterned thyroid tumors",
        "Prognostic implication of histological features associated with EHD2 expression in papillary thyroid carcinoma",
        "Molecular correlates and rate of lymph node metastasis of non-invasive follicular thyroid neoplasm with papillary-like nuclear features and invasive follicular variant papillary thyroid carcinoma: The impact of rigid criteria to distinguish non-invasive follicular thyroid neoplasm with papillary-like nuclear features"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bucheon-si",
            "@id": "60003087",
            "affilname": "The Catholic University of Korea",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60003087",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Nagasaki",
            "@id": "60136546",
            "affilname": "Graduate School of Biomedical Sciences",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60136546",
            "affiliation-country": "Japan"
        },
        {
            "affiliation-city": "Kamogawa",
            "@id": "60032609",
            "affilname": "Kameda Medical Center",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60032609",
            "affiliation-country": "Japan"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Ractchadapiseksompotch Fund",
        "Chulalongkorn University",
        "Ministry of Science and ICT",
        "National Research Foundation of Korea"
    ]
}